RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 30,159 Value ($000) $147 Avg Close $5.25 Range $4.45 - $7.15

Q2 2025

Shares 113,198 Value ($000) $573 Avg Close $4.91 Range $3.79 - $6.11

Q1 2025

Shares 257,001 Value ($000) $1,360 Avg Close $7.29 Range $5.19 - $12.36

Q4 2024

Shares 40,091 Value ($000) $271 Avg Close $6.72 Range $5.60 - $9.55

Q1 2024

Shares 21,096 Value ($000) $210 Avg Close $11.14 Range $8.68 - $15.74

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	30,159	$147	$5.25	$4.45 - $7.15
Q2 2025	113,198	$573	$4.91	$3.79 - $6.11
Q1 2025	257,001	$1,360	$7.29	$5.19 - $12.36
Q4 2024	40,091	$271	$6.72	$5.60 - $9.55
Q1 2024	21,096	$210	$11.14	$8.68 - $15.74